The company’s Merritt Island storefront marks record organic growth in the state

 Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary. Merritt Island will be home to the Company’s 60th dispensary in its home state of Florida and 62nd nationwide. The 6,500 sq. ft. location will directly support patients throughout Brevard County and along the Space Coast.


Located off the Merritt Island Causeway, the dispensary supports Trulieve’s goal of expanding and ensuring direct, reliable patient access to medical cannabis across its home state of Florida . It also joins the Company’s 59 other dispensaries statewide, including the nearby Melbourne , Titusville , and Port St. Lucie locations.

“When identifying new locations, we focus first on access; particularly, how we can best support patients across Florida . With approximately 90,000 new patients joining the state’s registry over the past six months, our goal is to ensure that they have access to the products they’ve come to rely on,” said Trulieve CEO Kim Rivers . “Our latest Merritt Island location is particularly exciting as it will not only be one of our larger stores, but it will allow us to better support our dedicated Trulievers along the Space Coast. From new patients to experienced ones, we’re looking forward to celebrating natural, effective relief across Brevard .”

In honor of the Company’s new dispensary, all patients — from those new to Trulieve to the dedicated Truliever community — will be eligible for a 25% in-store discount at the new Merritt Island location on opening day. In line with policies that have been adopted statewide, all visitors will be required to wear masks inside the dispensary. Additionally, only patients and their state-approved caregivers will be allowed inside the waiting room and dispensary at this time.

ANNOUNCING : Trulieve Merritt Island Opening
WHERE : 700 E Merritt Island Causeway, Merritt Island, Florida 32952
WHEN : Wednesday, October 7, 2020 , at 9:00 AM

In stores and online, patients will find Florida’s largest selection of THC and CBD products, available in a variety of delivery methods, including edibles, smokable cannabis, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers home delivery statewide for patients, and convenient in-store pick-up at its 60 dispensaries in locations across the state from Pensacola to Key West .

To assist patients with ordering, Trulieve has made our entire catalog of products available for online ordering, with in-store pickup, curbside pickup (at select locations), or statewide home delivery options available. In addition, patients can schedule a 30 minute complimentary virtual consultation with a Trulieve certified consultant. Patients can speak to a trained and certified consultant to help navigate questions on products and devices and review their doctor’s recommendation. To learn more about consultations, click here to read Trulieve’s blog .

Furthermore, to assist with CDC recommendations for social distancing and in compliance with additional company-enforced safety guidelines, several measures have been taken to ensure the health and well-being of employees and patients, including modifying the store layout, installation of plexiglass partitions and HEPA air filtration scrubbers in the dispensaries, increasing access to masks and sanitizer throughout the store for staff and visitors, utilizing visual aids to direct traffic throughout the store, and increasing the frequency of deep cleanings for all dispensaries.

Trulieve is closely monitoring the coronavirus situation and will update store policies as needed to ensure the safety of patients and staff; all updates will be shared directly on Trulieve’s website as they are enacted.

As the state’s leading medical cannabis provider, Trulieve’s employees are experienced, knowledgeable, and eager to help patients. Trulieve encourages potential patients, as well as patients who are new to cannabis and to our wide array of products, to connect with the staff in-store or through the online chat feature to learn more.

The Office of Medical Marijuana Use recently announced the registry was quickly approaching 425,000 registered medical marijuana patients with an active ID card, with Trulieve consistently selling approximately half of the state’s overall volume, per the Florida Department of Health. To support the state’s rapidly growing patient base, there are over 2,600 registered ordering physicians in the State of Florida .

For more information, please visit www.Trulieve.com .

About Trulieve
Trulieve is a vertically integrated “seed-to-sale” company and is the first and largest fully licensed medical cannabis company in the State of Florida . Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida , as well as directly to patients via home delivery. Trulieve also operates in California , Massachusetts , and Connecticut . Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF .

To learn more about Trulieve, visit www.Trulieve.com .

Cision View original content: http://www.prnewswire.com/news-releases/trulieve-reaches-60-florida-stores-announces-third-brevard-county-location-301146577.html

SOURCE Trulieve Cannabis Corp.

News Provided by PR Newswire via QuoteMedia

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less